NCT07507058 2026-04-02
Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Not yet recruiting
Clinical Trials
7 trialsNCT07358676 2026-01-22
A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT07327411 2026-01-08
Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow University
Phase 2 Not yet recruiting
NCT07084519 2025-07-24
Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Not yet recruiting
NCT06536699 2024-08-05
HYPORT-HN
Tata Medical Center
Phase NA Not yet recruiting
NCT05210270 2023-01-31
HYACINCT
University of Santo Tomas Hospital, Philippines
Phase 1/2 Not yet recruiting
NCT05253170 2022-03-11
Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients
Seoul National University Bundang Hospital
Phase 3 Not yet recruiting